Johns Hopkins spinout Neuraly launches with $36M funding round - Baltimore


Jul. 20, 2018 12:59 pm

Johns Hopkins spinout Neuraly launches with $36M funding round

The Maryland biotech startup is developing new treatments for Parkinson's disease and Alzheimer’s disease.

Lab space at Johns Hopkins' FastForward 1812.

(Photo by Stephen Babcock)

A Johns Hopkins biotech spinout working on new treatments for Alzheimer’s disease and Parkison’s disease officially launched with lots of fuel in the tank.

Neuraly said it raised $36 million in Series A funding from Korean venture funds including Smilegate Investment, InterVest, LB Investment, Magna Investment, Geon Investment and Dongkoo Bio&PharmaOctave Life Sciences and Maryland Venture Fund also participated.

The technology behind the treatment was born at the Johns Hopkins School of Medicine, and grew out of work by neuroscientists led by Institute for Cell Engineering director Ted Dawson. The company formed in 2016 as leaders looked to bring changes to treatment of neurodegenerative disorders.

“Currently, there aren’t any treatments that reverse, stop, or even slow neurodegeneration in diseases like Parkinson’s and Alzheimer’s. The treatments that do exist – all symptomatic – provide only temporary improvement in motor and cognitive function, but even these become less effective over time,” CEO Seulki Lee said in a statemen

Lee said the company is seeing promising early results in the potential for its main underlying product, called NLY01, to slow the progression of the diseases.

The Germantown-based company is looking to move into clinical trials in late 2018.

It’s the second eye-catching funding round from a Hopkins-originated biotech company this summer. WindMIL Therapeutics, which is targeting cancerposted a $32.5 million Series B round in June.

Already a member? Sign in here
Connect with companies from the community
New call-to-action


Following Boston accelerator, Pinkaloo launches charitable giving pilot with Eastern Bank

This Annapolis fintech startup wants to make it easier for banks to work with cannabis businesses

How law firm Nemphos Braue is guiding startups along the new business learning curve



How law firm Nemphos Braue is guiding startups along the new business learning curve

Baltimore, MD 21201

14 West

Junior Database Administrator

Apply Now
Baltimore, MD


Account Executive (Baltimore)

Apply Now


Vice President of Business Development

Apply Now

Hungry Harvest merges with North Carolina-based ugly produce delivery company

Biotech manufacturing center near BWI will have space to produce spinal muscular atrophy treatment

Genomics leader Illumina is opening a new center at University of Maryland BioPark



Building a data acquisition system? Don’t make this mistake


emocha Mobile Health

Software Engineer

Apply Now

RackTop Systems

API Guru

Apply Now


Front End Developer

Apply Now

Sign-up for daily news updates from Baltimore

Do NOT follow this link or you will be banned from the site!